Professional article
French

Effets secondaires systémiques et oropharyngés des corticostéroïdes inhalés

Published inRevue médicale suisse, vol. 8, no. 363, p. 2219-2223
Publication date2012
Abstract

The use of inhaled corticosteroids (ICS) is an important component of asthma management. Although their main impact is on airway inflammation, ICS are not devoid of systemic side effects (adrenal insufficiency, osteoporosis, brittle skin, ocular effects, growth retardation). Oropharyngeal side effects are also reported. These effects appear dose and duration dependent. They also vary according to the type of ICS used, its method of administration and drug interactions. It is recommended to titrate ICS to the lowest effective dose, to regularly reconsider their indication and to be aware of drug interactions. In addition, a change in ICS may have a favorable impact on side effects.

Keywords
  • Administration, Inhalation
  • Anti-Asthmatic Agents/administration & dosage/adverse effects/therapeutic use
  • Asthma/drug therapy
  • Dose-Response Relationship, Drug
  • Drug Interactions
  • Glucocorticoids/administration & dosage/adverse effects/therapeutic use
  • Humans
  • Oropharynx/drug effects/pathology
  • Pharyngeal Diseases/chemically induced
  • Time Factors
Citation (ISO format)
ROCHAT, Tamara, JANSSENS, Jean-Paul. Effets secondaires systémiques et oropharyngés des corticostéroïdes inhalés. In: Revue médicale suisse, 2012, vol. 8, n° 363, p. 2219–2223.
Main files (1)
Article (Published version)
accessLevelRestricted
Identifiers
ISSN of the journal1660-9379
431views
1downloads

Technical informations

Creation11/07/2015 5:41:00 PM
First validation11/07/2015 5:41:00 PM
Update time03/14/2023 11:49:11 PM
Status update03/14/2023 11:49:11 PM
Last indexation10/31/2024 1:52:55 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack